Evidence map›Paper›PMID 31384770›Full record

ArticleBMC chemistry2019

Antitumor effect of proanthocyanidin induced apoptosis in human colorectal cancer (HT-29) cells and its molecular docking studies.

Mani Suganya, Balasubramanian Mythili Gnanamangai, Balasubramani Ravindran, Soon Woong Chang, Arokiyaraj Selvaraj, Chandramohan Govindasamy, Mohamed Farouk Elsadek, Ponnusamy Ponmurugan

Open access · goldAbstract read
In one paragraph

Article in BMC chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in molecular biosciences · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Mani Suganya1Department of Biotechnology, K. S. Rangasamy College of Technology, Tiruchengode, Tamil Nadu 637215 India.
Balasubramanian Mythili Gnanamangai1Department of Biotechnology, K. S. Rangasamy College of Technology, Tiruchengode, Tamil Nadu 637215 India.
Balasubramani Ravindran2Department of Environmental Energy and Engineering, Kyonggi University, Youngtong-Gu, Suwon, 16227 South Korea.
Soon Woong Chang2Department of Environmental Energy and Engineering, Kyonggi University, Youngtong-Gu, Suwon, 16227 South Korea.
Arokiyaraj Selvaraj3Department of Food Science and Biotechnology, Sejong University, Seoul, Republic of Korea.ORCID 0000-0002-5486-7246
Chandramohan Govindasamy4Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh, 11433 Saudi Arabia.
Mohamed Farouk Elsadek4Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh, 11433 Saudi Arabia.
Ponnusamy Ponmurugan5Department of Botany, Bharathiar University, Coimbatore, Tamil Nadu 641 046 India.
Department of Biotechnology · INKing Saud Medical City · SAKyonggi University · KRBharathiar University · INSejong University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proanthocyanidin (PAC) is a promising compound that has displayed its potent antineoplastic properties with a specific intrinsic pathway. This precise us to explore the phyto-preventive effect of PAC against colon cancer (HT-29). The results showed that PAC inhibited the cell growth and GI

Indexed as

AO/EtBrCell cycle arrestMolecular dockingProanthocyanidin

Identifiers

PMID31384770
PMCPMC6661762
OpenAlexW2919778724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.